Novartis Gets First LABA/LAMA Formulation Approved In Europe And Japan
This article was originally published in PharmAsia News
Executive Summary
Novartis obtained approval in Japan for Ultibro inhalation capsule (indacaterol/glycopyrronium bromide) for maintenance therapy of adult COPD patients.